Antimyeloma Effects of the Heat Shock Protein 70 Molecular Chaperone Inhibitor MAL3-101

Multiple myeloma (MM) is the second most common hematologic malignancy and remains incurable, primarily due to the treatment-refractory/resistant nature of the disease. A rational approach to this compelling challenge is to develop new drugs that act synergistically with existing effective agents. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Braunstein, Marc J., Scott, Sadeaqua S., Scott, Craig M., Behrman, Shannon, Walter, Peter, Wipf, Peter, Coplan, Jeremy D., Chrico, William, Joseph, Danielle, Brodsky, Jeffrey L., Batuman, Olcay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3184436/
https://www.ncbi.nlm.nih.gov/pubmed/21977030
http://dx.doi.org/10.1155/2011/232037

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3184436/
https://www.ncbi.nlm.nih.gov/pubmed/21977030
http://dx.doi.org/10.1155/2011/232037

Ejemplares similares